The University of Wisconsin Carbone Cancer Center and Gundersen Center for Cancer and Blood Disorders have entered into a unique partnership to advance lung cancer research and patient services for the people of Wisconsin and beyond.
Together, we hope to advance the lung cancer agenda by:
- Creating awareness about this deadly disease;
- Engaging people to advocate on behalf of lung cancer research; and
- Raising needed dollars for basic and clinical research and translating this research into state-of-the-art patient care for patients with lung cancer.
Partner with us in investing in the UW Carbone Cancer Center and Gundersen Lutheran and the future of lung cancer research and treatment
Collaboration through the years…
The University of Wisconsin-Madison and Gundersen have enjoyed a relationship regarding education and research for nearly 85 years. The nation’s first formalized Preceptorship Program for senior medical students was established between the University of Wisconsin School of Medicine and Public Health and Gundersen in 1926. It continues to this day. Gundersen serves as the longest running host site for a preceptorship in the nation.
Over the years, the relationship between the entities has expanded and become more sophisticated. In the mid-'60s clinic doctors, led by Cameron Gundersen, worked with the university’s Wayne Thompson, PhD, professor of preventative medicine and a Yale specialist in arboviruses, to document and describe La Crosse Encephalitis. In the late '60s Sigurd Sivertson, MD, Director of Medical Education and Research, left Gundersen Clinic to become Assistant Dean for Clinical Affairs at the UW. In the 1980s, a collaboration between Ron Shell, PhD, UW professor of microbiology and Steve Callister, PhD, senior research scientist for the Gundersen’s Microbiology Research Laboratory focused on Lyme disease research and the development of an animal vaccine.
In 1996 Gundersen was named the Western Clinical Campus of the UW School of Medicine and Public Health. Each year, more than 100 third and fourth-year medical students do clinical rotations in La Crosse. The current UW Medical School building also honors the long-term relationship with the Gundersen House within its walls.
Communicating the Facts
- Lung cancer kills more than breast, colon and prostate cancers combined. It is the leading cause of death from all types of cancer worldwide, and the second leading cause of death in the U.S. following only heart disease.
- More than 85% of lung cancer patients die from the disease. This high death rate makes lung cancer one of the most lethal cancers.
- One in five women and one in 12 men diagnosed with lung cancer have never smoked.
- About $1 in national funding is provided for research for patients diagnosed with lung cancer compared to $26 provided for research for breast cancer patients.
UW Carbone Cancer Center and Gundersen Medical Foundation are joining forces to create a $1 million endowment fund to advance lung cancer initiatives.
The Lung Cancer Endowment Fund will:
- Help advance basic lung cancer research at the UW and, in turn, advance clinical research at Gundersen;
- Explore innovative research (pilot projects) at both institutions;
- Recruit and retain leading lung cancer researchers; and
- Improve the patient experience for patients with lung cancer.
Leading this initiative is the Lung Cancer Task Force, comprised of of statewide patients, family, friends, community leaders and concerned supporters. It has been developed to drive fundraising, patient and legislative advocacy as well as marketing and special events.
For More Information:
Robyn Tanke, CFRE
Gundersen Medical Foundation
(608) 775-4711, firstname.lastname@example.org